Search

everythinglearnresearchcommunity

for

Search:↓

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

The document explains various skin conditions and their treatments.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Erbium YAG laser treatment, combined with conventional therapy, can effectively reduce hair loss and promote hair growth in men with androgenetic alopecia.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.